Eupraxia Pharmaceuticals (TSX:EPRX) Purchase Of Business : C$0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Eupraxia Pharmaceuticals Purchase Of Business?

Eupraxia Pharmaceuticals's purchase of business for the three months ended in Mar. 2025 was C$0.00 Mil. It means Eupraxia Pharmaceuticals spent C$0.00 Mil on purchasing business. Eupraxia Pharmaceuticals's purchase of business for the trailing twelve months (TTM) ended in Mar. 2025 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Dec. 2024 ), Eupraxia Pharmaceuticals spent the same money on purchasing business in Mar. 2025 (C$0.00 Mil).

Eupraxia Pharmaceuticals Purchase Of Business Historical Data

The historical data trend for Eupraxia Pharmaceuticals's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eupraxia Pharmaceuticals Purchase Of Business Chart

Eupraxia Pharmaceuticals Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Purchase Of Business

Get a 7-Day Free Trial

Eupraxia Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Purchase Of Business	Get a 7-Day Free Trial															-	-	-	-	-

Eupraxia Pharmaceuticals Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Eupraxia Pharmaceuticals Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Eupraxia Pharmaceuticals's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Eupraxia Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eupraxia Pharmaceuticals Inc (TSX:EPRX) » Definitions » Purchase Of Business

Comparable Companies

Traded in Other Exchanges

EPRX:USA X43:Germany

Address

201 2067 Cadboro Bay Road, Victoria, BC, CAN, V8R 5G4

Website

https://www.eupraxiapharma.com

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

Executives

Michael Wilmink	Director
Amanda Michelle Malone	Senior Officer
Paul Anthony Brennan	Senior Officer
James Allen Helliwell	Director
James Besser	Director or Senior Officer of 10% Security Holder
Morgan Frank	Director or Senior Officer of 10% Security Holder
Llc Manchester Management Company	10% Security Holder
John Montalbano	Director